Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

Updated Guidance for Performing Temperature Checks at Military MTFs and DTFs

Publication
10/21/2020

This guidance is an update to Defense Health Agency Return to Full Operations Concept of Operations, V5.0 (June 12, 2020) as it pertains to temperature checks in MTFs and DTFs. Based on recommendations from the Centers for Disease Control (CDC), previous guidance directed MTFs to take the temperature of all individuals entering the facility. Effective immediately, temperature checks are not required; however, screening of individuals entering MTFs and DTFs and healthcare personnel on duty in the MTF or DTF is to continue.

Recommended Content:

Coronavirus

Fort Irwin DENTAC strives to reach readiness perfection

Article
10/21/2020
Image of patient getting a dental exam

To accommodate an entire installation, the dental clinic extended its hours.

Recommended Content:

Public Health | Coronavirus | MHS GENESIS | Combat Support

Specialized robots used to disinfect NH TwentyninePalms

Article
10/21/2020
Hospital personnel standing with a cleaning robot

The robotic units are designed to complement manual cleaning.

Recommended Content:

Public Health | Coronavirus

Navy pharmacy techs support COVID-19 and MHS GENESIS efforts

Article
10/20/2020
Navy personnel in a pharmacy

Hospital Corpsman 1st Class Aaron Souders is highlighted for his work as a Navy pharmacy technician.

Recommended Content:

Coronavirus | MHS GENESIS | Combat Support

Navy tele-health supports Guam civilian hospital during COVID-19

Article
10/19/2020
Woman sitting in front of several computer monitors

[T]his is the first-ever DoD tasking for telemedicine support in response to a request from civil authorities for aid.

Recommended Content:

Coronavirus | Combat Support | Global Health Engagement

Navy unit provided COVID-19 support to Peruvian First Responders

Article
10/16/2020
Fireman getting COVID test in firehouse garage

The province of Callao has the second highest number of COVID-19 cases in Peru.

Recommended Content:

Coronavirus | Global Health Engagement

COVID-19 Social Media Toolkit

Publication
10/16/2020

These messages are provided for you to use on your platforms with any of the images from the COVID-19 Toolkit.

Recommended Content:

Coronavirus

DoD COVID-19 Practice Management Guide Version 6

Technical Document
10/16/2020

This Practice Management Guide does not supersede DoD Policy. It is based upon the best information available at the time of publication. It is designed to provide information and assist decision making. It is not intended to define a standard of care and should not be construed as one. Neither should it be interpreted as prescribing an exclusive course of management. It was developed by experts in this field. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of this guideline is responsible for evaluating the appropriateness of applying it in the setting of any particular clinical situation. The Practice Management Guide is not intended to represent TRICARE policy. Further, inclusion of recommendations for specific testing and/or therapeutic interventions within this guide does not guarantee coverage of civilian sector care. Additional information on current TRICARE benefits may be found at www.tricare.mil or by contacting your regional TRICARE Managed Care Support Contractor.

Recommended Content:

Coronavirus

DHA Director outlines how MHS standardization bolsters reform

Article
10/15/2020
Two soldiers in masks, talking

How COVID-19 repositioned the best laid plans of the DoD.

Recommended Content:

Coronavirus | Joint Health Information Exchange | MHS GENESIS | MHS Transformation

Annual flu vaccine remains a health priority during COVID-19 era

Article
10/13/2020
Military personnel getting flu shot

Annual vaccine is a covered TRICARE benefit.

Recommended Content:

Immunization Healthcare | Vaccine-Preventable Diseases | Public Health | Coronavirus

Pilot DoD/VA hearing program virtually trains technicians

Article
10/9/2020
Military personnel sitting in front of laptop

HCE virtually trains hearing technicians during COVID-19.

Recommended Content:

Coronavirus | Hearing Loss

MHS Minute: Heroes Behind the Mask

Video
10/8/2020
Image of MHS Minute Carousel

In the face of a global threat, healthcare heroes across the MHS have donned their mask, and served on the front line of the battle against COVID-19. Tune in to this month's "MHS Minute" to learn more!

Recommended Content:

Coronavirus

‘I am Navy Medicine’ – helping another in need - Hospitalman Grace Pridmore of NMRTC Bremerton

Article
10/7/2020
Corpsman conviction of care, compassion and competence…Hospitalman Grace Pridmore, from Kellyville, Okla., assigned to Navy Medicine Readiness and Training Command (NMRTC) Bremerton Detachment Puget Sound Naval Shipyard (PSNS), was acknowledged for her selfless effort by Capt. Shannon J. Johnson, NMRTC Bremerton commanding officer, for identifying another Sailor at risk and taking quick action to help get the Sailor to the appropriate level of care, very possibly saving a life (official Navy photo by Douglas H Stutz, NHB/NMRTC Bremerton public affairs officer).

It takes more than just awareness to respond to someone showing signs of distress.

Recommended Content:

Coronavirus | Mental Health Care | Mental Wellness

DHA priorities focused on readiness, patients, outcomes

Article
10/7/2020
Defense Health Agency Director Army Lt. Gen. Ronald Place speaks at a podium.

Adaptation key to providing outstanding care to beneficiaries.

Recommended Content:

Health Readiness | Combat Support | Access to Health Care | Coronavirus | Convalescent Plasma Collection Program

Maintaining positive social media interactions during COVID-19

Article
10/2/2020
Image of soldier looking at his cell phone

Experts discuss good, bad of social media during pandemic.

Recommended Content:

Coronavirus
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 21

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.